-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Oscar Health, Raises Price Target to $19

Benzinga·05/07/2026 11:46:46
Listen to the news
Baird analyst Michael Ha maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price target from $15 to $19.